15/120
0.6 / 5 stars
All 120 Win/Lose results shown below
SKIN Roast Me summary
SkinHealth Systems Inc. (SKIN). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSKIN / S&P -22.13% / 15.20% |
LoseSKIN / S&P -6.46% / 15.00% |
LoseSKIN / S&P SKIN unavailable / 50.40% |
| 2026-Q10/3 |
LoseSKIN / S&P -35.97% / -4.33% |
LoseSKIN / S&P -8.17% / 11.30% |
LoseSKIN / S&P SKIN unavailable / 27.70% |
| 2025-Q40/3 |
LoseSKIN / S&P -30.15% / 2.65% |
LoseSKIN / S&P -10.02% / 9.00% |
LoseSKIN / S&P SKIN unavailable / 13.40% |
| 2025-Q30/3 |
LoseSKIN / S&P 4.19% / 8.12% |
LoseSKIN / S&P -13.15% / 4.61% |
LoseSKIN / S&P SKIN unavailable / 13.45% |
| 2025-Q21/3 |
WinSKIN / S&P 42.54% / 10.94% |
LoseSKIN / S&P -15.34% / 4.83% |
LoseSKIN / S&P SKIN unavailable / 10.63% |
| 2025-Q10/3 |
LoseSKIN / S&P -15.72% / -4.27% |
LoseSKIN / S&P -17.97% / 4.98% |
LoseSKIN / S&P SKIN unavailable / 10.57% |
| 2024-Q41/3 |
WinSKIN / S&P 10.42% / 2.41% |
LoseSKIN / S&P -16.00% / 5.25% |
LoseSKIN / S&P SKIN unavailable / 6.15% |
| 2024-Q30/3 |
LoseSKIN / S&P -25.00% / 5.89% |
LoseSKIN / S&P -12.94% / 5.89% |
LoseSKIN / S&P SKIN unavailable / 6.11% |
| 2024-Q20/3 |
LoseSKIN / S&P -56.76% / 4.28% |
LoseSKIN / S&P -6.26% / 5.38% |
LoseSKIN / S&P SKIN unavailable / 5.12% |
| 2024-Q11/3 |
WinSKIN / S&P 42.77% / 10.56% |
LoseSKIN / S&P 4.35% / 5.71% |
LoseSKIN / S&P SKIN unavailable / 5.59% |
| 2023-Q41/3 |
LoseSKIN / S&P -48.34% / 11.69% |
WinSKIN / S&P 8.78% / 6.81% |
LoseSKIN / S&P SKIN unavailable / 7.78% |
| 2023-Q31/3 |
LoseSKIN / S&P -28.08% / -3.27% |
WinSKIN / S&P 15.53% / 7.52% |
LoseSKIN / S&P -505.88% / -5.03% |
| 2023-Q21/3 |
LoseSKIN / S&P -33.73% / 8.74% |
WinSKIN / S&P 20.21% / 9.50% |
LoseSKIN / S&P SKIN unavailable / -8.57% |
| 2023-Q12/3 |
WinSKIN / S&P 38.79% / 7.50% |
WinSKIN / S&P 30.83% / 10.77% |
LoseSKIN / S&P SKIN unavailable / -15.69% |
| 2022-Q41/3 |
LoseSKIN / S&P -22.82% / 7.56% |
WinSKIN / S&P 40.68% / 11.88% |
LoseSKIN / S&P SKIN unavailable / -17.99% |
| 2022-Q31/3 |
LoseSKIN / S&P -8.32% / -4.88% |
WinSKIN / S&P 57.05% / 13.47% |
LoseSKIN / S&P SKIN unavailable / -1.41% |
| 2022-Q21/3 |
LoseSKIN / S&P -23.82% / -16.10% |
WinSKIN / S&P 74.27% / 13.71% |
LoseSKIN / S&P SKIN unavailable / 11.04% |
| 2022-Q11/3 |
LoseSKIN / S&P -30.13% / -4.60% |
WinSKIN / S&P 114.74% / 15.97% |
LoseSKIN / S&P SKIN unavailable / 42.23% |
| 2021-Q41/3 |
LoseSKIN / S&P -6.97% / 11.03% |
WinSKIN / S&P 118.39% / 15.00% |
LoseSKIN / S&P SKIN unavailable / 96.40% |
| 2021-Q31/3 |
WinSKIN / S&P 54.58% / 0.58% |
LoseSKIN / S&P SKIN unavailable / 10.77% |
LoseSKIN / S&P SKIN unavailable / 69.42% |
| 2021-Q21/3 |
WinSKIN / S&P 55.56% / 8.55% |
LoseSKIN / S&P SKIN unavailable / 6.58% |
LoseSKIN / S&P SKIN unavailable / 51.81% |
| 2021-Q10/3 |
LoseSKIN / S&P -4.51% / 6.17% |
LoseSKIN / S&P SKIN unavailable / -1.06% |
LoseSKIN / S&P SKIN unavailable / 7.39% |
| 2020-Q40/3 |
LoseSKIN / S&P SKIN unavailable / 12.15% |
LoseSKIN / S&P -28.53% / -3.72% |
LoseSKIN / S&P SKIN unavailable / -33.42% |
| 2020-Q30/3 |
LoseSKIN / S&P SKIN unavailable / 8.93% |
LoseSKIN / S&P SKIN unavailable / -2.04% |
LoseSKIN / S&P SKIN unavailable / -27.10% |
| 2020-Q20/3 |
LoseSKIN / S&P SKIN unavailable / 20.54% |
LoseSKIN / S&P SKIN unavailable / -0.46% |
LoseSKIN / S&P SKIN unavailable / -27.11% |
| 2020-Q10/3 |
LoseSKIN / S&P SKIN unavailable / -19.60% |
LoseSKIN / S&P SKIN unavailable / 3.47% |
LoseSKIN / S&P SKIN unavailable / -14.75% |
| 2019-Q40/3 |
LoseSKIN / S&P SKIN unavailable / 9.07% |
LoseSKIN / S&P SKIN unavailable / 5.36% |
LoseSKIN / S&P SKIN unavailable / 2.99% |
| 2019-Q30/3 |
LoseSKIN / S&P SKIN unavailable / 1.70% |
LoseSKIN / S&P SKIN unavailable / 5.02% |
LoseSKIN / S&P SKIN unavailable / 0.21% |
| 2019-Q20/3 |
LoseSKIN / S&P SKIN unavailable / 4.30% |
LoseSKIN / S&P SKIN unavailable / 6.64% |
LoseSKIN / S&P SKIN unavailable / 8.65% |
| 2019-Q10/3 |
LoseSKIN / S&P SKIN unavailable / 13.65% |
LoseSKIN / S&P SKIN unavailable / 8.12% |
LoseSKIN / S&P SKIN unavailable / 14.29% |
| 2018-Q40/3 |
LoseSKIN / S&P SKIN unavailable / -13.52% |
LoseSKIN / S&P SKIN unavailable / 9.05% |
LoseSKIN / S&P SKIN unavailable / 18.23% |
| 2018-Q30/3 |
LoseSKIN / S&P SKIN unavailable / 7.71% |
LoseSKIN / S&P SKIN unavailable / 10.21% |
LoseSKIN / S&P SKIN unavailable / 19.06% |
| 2018-Q20/3 |
LoseSKIN / S&P SKIN unavailable / 3.43% |
LoseSKIN / S&P SKIN unavailable / 9.03% |
LoseSKIN / S&P SKIN unavailable / 14.46% |
| 2018-Q10/3 |
LoseSKIN / S&P SKIN unavailable / -0.76% |
LoseSKIN / S&P SKIN unavailable / 7.68% |
LoseSKIN / S&P SKIN unavailable / 12.46% |
| 2017-Q40/3 |
LoseSKIN / S&P SKIN unavailable / 6.64% |
LoseSKIN / S&P SKIN unavailable / 7.03% |
LoseSKIN / S&P SKIN unavailable / 13.82% |
| 2017-Q30/3 |
LoseSKIN / S&P SKIN unavailable / 4.48% |
LoseSKIN / S&P SKIN unavailable / 5.68% |
LoseSKIN / S&P SKIN unavailable / 17.57% |
| 2017-Q20/3 |
LoseSKIN / S&P SKIN unavailable / 3.09% |
LoseSKIN / S&P SKIN unavailable / 4.83% |
LoseSKIN / S&P SKIN unavailable / 17.74% |
| 2017-Q10/3 |
LoseSKIN / S&P SKIN unavailable / 6.07% |
LoseSKIN / S&P SKIN unavailable / 3.67% |
LoseSKIN / S&P SKIN unavailable / 13.32% |
| 2016-Q40/3 |
LoseSKIN / S&P SKIN unavailable / 3.82% |
LoseSKIN / S&P SKIN unavailable / 2.09% |
LoseSKIN / S&P SKIN unavailable / 7.05% |
| 2016-Q30/3 |
LoseSKIN / S&P SKIN unavailable / 3.85% |
LoseSKIN / S&P SKIN unavailable / 0.20% |
LoseSKIN / S&P SKIN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | SKIN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -67.11% | 20.78% |
| Annualized return | -67.11% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | SKIN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.51% | 83.14% |
| Annualized return | -52.20% | 12.86% |
10Y · 2020-11-24 to 2026-08-28
| Metric | SKIN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -93.69% | 319.30% |
| Annualized return | -24.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |